Dr
Benjamin
Janutta

Senior Patent Attorney

Munich Office

Electronics

Telephone. +49(0) 891 259 9600
Mobile. +49(0) 177 754 1817
Email. [email protected]

Experience

Benjamin works with a range of clients from SMEs to large-scale enterprises. Besides drafting of patent applications and prosecution, Benjamin offers guidance to his clients in terms of patent portfolio management.

Benjamin has significant expertise in electronic engineering, particular communication engineering, 4G, 5G, software, and telecommunications, particularly wireless communications, including standard essential cases. Furthermore, Benjamin has experience in semiconductor technologies and display technologies.

Benjamin also advises his clients in the fields of trade mark and design law.

Benjamin holds a Diploma degree and a Dr. rer. nat. in Physics at the Hamburg University. During his studies Benjamin worked at the Laboratori Nazionali del Gran Sasso (LNGS), in Assergi, Italy, where he was responsible for commissioning parts of the readout electronics of an international particle physics experiment investigated neutrino oscillations. As a postdoctoral researcher at the TU Dresden he was involved in investigating rare nuclear decays at LNGS using room-temperature CdZnTe semiconductor detectors.

Benjamin is a Patentanwalt (German Patent Attorney), European Patent Attorney as well as European Trade Mark and Design Attorney.

Qualifications

Patent Attorney

European
German

Patentanwalt


MPHYS

Physics Diploma, University of Hamburg

PHD

Dr. rer. nat., Particle physics, University Hamburg

Related News

Event - 30th April 2022

INTA 2022 Annual Meeting Live+

The HGF European team will be attending the INTA 2022 Annual Meeting Live+. It is being held on 30th April – 4th May in Washington, D.C. INTA brings together the …

Event details

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 19th May 2022

HGF Complete webinar: comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details
Event - 14th April 2022

HGF Complete webinar: unregistered trade mark rights in the EU and UK

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers discuss trade marks and designs in the EU and the UK. We compare and contrast the …

Event details
Event - 31st March 2022

HGF Complete webinar: trade mark opposition and invalidity proceedings

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details
Event - 17th March 2022

HGF Complete webinar: trade mark application procedures before the EUIPO and UKIPO

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.